-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Multi-Disciplinary Hematologic Disorders: What Is the Hematologist's Role? - Live Q&A

Program: Education Program
Hematology Disease Topics & Pathways:
Bleeding and Clotting, Diseases, Therapies, Clinical Practice (e.g. Guidelines, Health Outcomes and Services, and Survivorship, Value; etc.)
Sunday, December 12, 2021: 9:30 AM-10:15 AM
C208-C210, Level 2, Building C (Georgia World Congress Center)

Description:
The management of patients with hematologic disorders often involves multi-disciplinary care, both for primary hematologic diseases that affect multiple organ systems, as well as for diseases with secondary hematologic complications. This educational session will explore the role of the hematologist in three diseases that necessarily involve multiple subspecialists: HHT, CTEPH, and cirrhosis. Using a case-based approach, this program will highlight the role of hematology within a broader context of disease management.

 

Dr. Adrienne Hammill will discuss the challenges of making a diagnosis of HHT given widely variable clinical presentations using a case-based approach.  She will review the pathophysiology of this disease and present screening strategies and therapeutic options in accordance with the Second International Guidelines for the Diagnosis and Management of HHT published in 2020.  Focusing on ways these patients can present to hematologists, she will discuss the multidisciplinary team approach and coordination required for optimal care of patients with HHT.

Dr. Karlyn Martin will outline the evaluation for and treatment of chronic thromboembolic pulmonary hypertension (CTEPH). Using a case-based approach, she will review criteria for CTEPH and CTED, and discuss how to approach the diagnostic evaluation of CTEPH. Finally, she will present an approach to treatment, including medical, surgical, and interventional therapies that require multi-disciplinary care.

Dr Lara Roberts will discuss the evidence for rebalanced hemostasis in advanced chronic liver disease and the dual propensity to bleeding and thrombosis. Using a case-based approach, the implications and management of abnormal coagulation and/or thrombocytopenia in the periprocedural setting will be outlined. Finally, she will address the challenges of anticoagulation for portal vein thrombosis.

Chair:
Karlyn A. Martin, MD, Northwestern University
Disclosures:
Martin: Penumbra: Other: Scientific Advisory Board; Janssen: Research Funding.
Panelists:
Adrienne M Hammill, MD, PhD, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine , Karlyn A. Martin, MD, Northwestern University and Lara N Roberts, MD, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust
Disclosures:
Martin: Janssen: Research Funding; Penumbra: Other: Scientific Advisory Board.
The management of patients with hematologic disorders often involves multi-disciplinary care, both for primary hematologic diseases that affect multiple organ systems, as well as for diseases with secondary hematologic complications. This educational session will explore the role of the hematologist in three diseases that necessarily involve multiple subspecialists: HHT, CTEPH, and cirrhosis. Using a case-based approach, this program will highlight the role of hematology within a broader context of disease management.

 

Dr. Adrienne Hammill will discuss the challenges of making a diagnosis of HHT given widely variable clinical presentations using a case-based approach.  She will review the pathophysiology of this disease and present screening strategies and therapeutic options in accordance with the Second International Guidelines for the Diagnosis and Management of HHT published in 2020.  Focusing on ways these patients can present to hematologists, she will discuss the multidisciplinary team approach and coordination required for optimal care of patients with HHT.

Dr. Karlyn Martin will outline the evaluation for and treatment of chronic thromboembolic pulmonary hypertension (CTEPH). Using a case-based approach, she will review criteria for CTEPH and CTED, and discuss how to approach the diagnostic evaluation of CTEPH. Finally, she will present an approach to treatment, including medical, surgical, and interventional therapies that require multi-disciplinary care.

Dr Lara Roberts will discuss the evidence for rebalanced hemostasis in advanced chronic liver disease and the dual propensity to bleeding and thrombosis. Using a case-based approach, the implications and management of abnormal coagulation and/or thrombocytopenia in the periprocedural setting will be outlined. Finally, she will address the challenges of anticoagulation for portal vein thrombosis.

See more of: Education Program